Netherlands	O
There	O
have	O
been	O
a	O
number	O
of	O
cases	O
of	O
meningococcal	O
disease	O
which	O
are	O
associated	O
with	O
returnees	O
from	O
the	O
Haj	O
and	O
their	O
close	O
contacts	O
.	O
France	O
-	O
Update	O
.	O
The	O
number	O
of	O
cases	O
of	O
meningococcal	O
disease	O
associated	O
with	O
pilgrims	O
who	O
have	O
travelled	O
for	O
the	O
Haj	O
has	O
increased	O
,	O
and	O
the	O
total	O
number	O
of	O
cases	O
to	O
date	O
is	O
14	O
,	O
including	O
4	O
deaths	O
.	O
Eleven	O
of	O
the	O
confirmed	O
cases	O
were	O
of	O
meningococcal	O
serogroup	O
W135	O
.	O
United	O
Kingdom	O
-	O
Update	O
.	O
The	O
number	O
of	O
cases	O
of	O
meningococcal	O
disease	O
linked	O
to	O
pilgrims	O
has	O
increased	O
,	O
and	O
is	O
now	O
22	O
with	O
4	O
deaths	O
.	O
Twenty	O
of	O
the	O
confirmed	O
cases	O
are	O
of	O
meningococcal	O
serogroup	O
W135	O
and	O
1	O
of	O
_	O
N.	O
meningitidis	O
_	O
serogroup	O
A	O
.	O
The	O
onset	O
of	O
the	O
last	O
case	O
of	O
meningococcal	O
disease	O
reported	O
to	O
date	O
-LRB-	O
in	O
a	O
contact	O
-RRB-	O
was	O
on	O
11	O
April	O
.	O
Oman	O
.	O
There	O
have	O
been	O
12	O
cases	O
to	O
date	O
,	O
all	O
have	O
recovered	O
.	O
Of	O
these	O
,	O
3	O
were	O
pilgrims	O
-LRB-	O
2	O
males	O
aged	O
40	O
and	O
55	O
years	O
and	O
1	O
female	O
aged	O
60	O
years	O
-RRB-	O
returning	O
from	O
the	O
Haj	O
,	O
and	O
9	O
cases	O
were	O
close	O
contacts	O
of	O
those	O
returned	O
from	O
the	O
Haj	O
.	O
The	O
ages	O
of	O
these	O
patients	O
ranged	O
from	O
6	O
months	O
to	O
80	O
years	O
.	O
The	O
date	O
of	O
onset	O
of	O
the	O
first	O
case	O
was	O
20	O
March	O
,	O
and	O
the	O
most	O
recent	O
case	O
was	O
reported	O
on	O
6	O
April	O
.	O
Seven	O
of	O
the	O
confirmed	O
cases	O
are	O
of	O
meningococcal	O
serogroup	O
W135	O
and	O
2	O
of	O
_	O
Neisseria	O
meningitidis	O
_	O
serogroup	O
A.	O
Saudi	O
Arabia	O
.	O
total	O
of	O
199	O
cases	O
with	O
55	O
deaths	O
has	O
been	O
reported	O
since	O
the	O
Haj	O
last	O
month	O
.	O
Bacteriological	O
investigations	O
have	O
revealed	O
_	O
N.	O
meningitidis	O
_	O
serogroup	O
A	O
in	O
55	O
cases	O
,	O
serogroup	O
W135	O
in	O
30	O
and	O
serogroup	O
B	O
in	O
1	O
case	O
.	O
record	O
number	O
of	O
pilgrims	O
-LRB-	O
around	O
1.3	O
million	O
-RRB-	O
travelled	O
to	O
Saudi	O
Arabia	O
for	O
the	O
Haj	O
this	O
year	O
,	O
with	O
an	O
increase	O
in	O
the	O
number	O
from	O
South-East	O
Asia	O
.	O
The	O
health	O
authorities	O
are	O
monitoring	O
the	O
situation	O
closely	O
.	O
Case	O
management	O
and	O
contact	O
tracing	O
are	O
taking	O
place	O
.	O
Netherlands	O
.	O
There	O
have	O
been	O
2	O
confirmed	O
cases	O
and	O
1	O
probable	O
case	O
of	O
meningococcal	O
disease	O
in	O
close	O
contacts	O
of	O
pilgrims	O
returning	O
from	O
the	O
Haj	O
.	O
The	O
dates	O
of	O
onset	O
in	O
the	O
confirmed	O
cases	O
were	O
5	O
and	O
6	O
April	O
.	O
Serogroup	O
W135	O
_	O
Neisseria	O
meningitidis	O
_	O
has	O
been	O
isolated	O
from	O
both	O
.	O
Meningococcal	O
disease	O
.	O
As	O
with	O
all	O
types	O
of	O
meningococcal	O
disease	O
,	O
early	O
diagnosis	O
and	O
treatment	O
are	O
essential	O
.	O
The	O
symptoms	O
of	O
group	O
W135	O
meningococcal	O
disease	O
are	O
the	O
same	O
as	O
for	O
other	O
groups	O
of	O
the	O
disease	O
:	O
sudden	O
onset	O
of	O
intense	O
headache	O
,	O
high	O
fever	O
,	O
nausea	O
,	O
and	O
vomiting	O
,	O
photophobia	O
and	O
stiff	O
neck	O
.	O
The	O
most	O
severe	O
clinical	O
form	O
of	O
the	O
disease	O
,	O
meningococcal	O
septicaemia	O
can	O
be	O
presented	O
by	O
abrupt	O
onset	O
,	O
high	O
fever	O
,	O
petechial	O
rash	O
or	O
purpura	O
.	O
WHO	O
recommends	O
that	O
chemoprophylaxis	O
be	O
given	O
to	O
close	O
contacts	O
of	O
the	O
cases	O
,	O
such	O
as	O
persons	O
sleeping	O
in	O
the	O
same	O
dwelling	O
.	O
In	O
most	O
countries	O
rifampicin	O
is	O
recommended	O
.	O
Immunization	O
against	O
meningococcal	O
disease	O
A+C	O
has	O
been	O
an	O
entry	O
requirement	O
by	O
Saudi	O
Arabia	O
for	O
pilgrims	O
travelling	O
to	O
the	O
Haj	O
.	O
However	O
,	O
the	O
meningococcal	O
A+C	O
vaccine	O
does	O
not	O
protect	O
against	O
group	O
W135	O
infection	O
.	O
WHO	O
encourages	O
national	O
reference	O
laboratories	O
to	O
closely	O
monitor	O
meningococcal	O
disease	O
.	O
Germany	O
.	O
A	B-VIC
55	I-VIC
year-old	I-VIC
female	I-VIC
of	O
Turkish	O
nationality	O
living	O
in	O
Germany	O
returned	O
from	O
Saudi	O
Arabia	O
on	O
28th	O
March	O
.	O
She	O
was	O
not	O
feeling	O
well	O
in	O
the	O
plane	O
and	O
was	O
admitted	O
to	O
a	O
local	O
hospital	O
after	O
landing	O
in	O
Cologne	O
in	O
reduced	O
general	O
condition	O
.	O
meningitis	O
was	O
diagnosed	O
and	O
treatment	O
started	O
.	O
According	O
to	O
her	O
husband	O
she	O
had	O
been	O
vaccinated	O
for	O
meningococci	O
.	O
Neisseria	O
meningitidis	O
Serogroup	O
B	O
,	O
Serotype	O
2a	O
and	O
Subtype	O
PI	O
.2	O
was	O
confirmed	O
by	O
a	O
national	O
reference	O
laboratory	O
.	O
--	O
Prof.	O
Pramod	O
M.	O
Shah	O
Frankfurt	O
Germany	O
e-mail	O
:	O
shah@em.uni-frankfurt.de......................................jw	O
/	O
es	O
--	O
